Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions

Conditions:   Coronary Artery Disease;   Diabetes Mellitus;   Percutaneous Coronary Intervention Interventions:   Drug: Empagliflozin 10Mg Tab;   Drug: hypoglycemic therapy Sponsor:   Research Institute for Complex Problems of Cardiovascular Diseases, Russia Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials